Dexamethasone in hyperleukocytic acute myeloid leukemia by Sarah

  • Slides: 8
Download presentation
Dexamethasone in hyperleukocytic acute myeloid leukemia by Sarah Bertoli, Muriel Picard, Emilie Bérard, Emmanuel

Dexamethasone in hyperleukocytic acute myeloid leukemia by Sarah Bertoli, Muriel Picard, Emilie Bérard, Emmanuel Griessinger, Clément Larrue, Pierre Luc Mouchel, François Vergez, Suzanne Tavitian, Edwige Yon, Jean Ruiz, Eric Delabesse, Isabelle Luquet, Laetitia Karine Linares, Estelle Saland, Martin Carroll, Gwenn Danet-Desnoyers, Audrey Sarry, Françoise Huguet, Jean Emmanuel Sarry, and Christian Récher haematol Volume 103(6): 988 -998 June 3, 2018 © 2018 by Ferrata Storti Foundation

Study flowchart. y: years; WBC: white blood cell; OS: overall survival; CR: complete response.

Study flowchart. y: years; WBC: white blood cell; OS: overall survival; CR: complete response. Sarah Bertoli et al. Haematologica 2018; 103: 988 -998 © 2018 by Ferrata Storti Foundation

Characteristics of the 160 acute myeloid leukemia patients with hyperleukocytosis. Sarah Bertoli et al.

Characteristics of the 160 acute myeloid leukemia patients with hyperleukocytosis. Sarah Bertoli et al. Haematologica 2018; 103: 988 -998 © 2018 by Ferrata Storti Foundation

Patients’ outcomes during induction chemotherapy according to study group. Sarah Bertoli et al. Haematologica

Patients’ outcomes during induction chemotherapy according to study group. Sarah Bertoli et al. Haematologica 2018; 103: 988 -998 © 2018 by Ferrata Storti Foundation

Estimates of survival end points and incidence of relapse. Sarah Bertoli et al. Haematologica

Estimates of survival end points and incidence of relapse. Sarah Bertoli et al. Haematologica 2018; 103: 988 -998 © 2018 by Ferrata Storti Foundation

Multivariate analysis for overall survival. Sarah Bertoli et al. Haematologica 2018; 103: 988 -998

Multivariate analysis for overall survival. Sarah Bertoli et al. Haematologica 2018; 103: 988 -998 © 2018 by Ferrata Storti Foundation

Impact of dexamethasone on chemoresistance. Sarah Bertoli et al. Haematologica 2018; 103: 988 -998

Impact of dexamethasone on chemoresistance. Sarah Bertoli et al. Haematologica 2018; 103: 988 -998 © 2018 by Ferrata Storti Foundation

Activity of dexamethasone against acute myeloid leukemia (AML). Sarah Bertoli et al. Haematologica 2018;

Activity of dexamethasone against acute myeloid leukemia (AML). Sarah Bertoli et al. Haematologica 2018; 103: 988 -998 © 2018 by Ferrata Storti Foundation